课题基金 / 基金详情

A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY

A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY
每日给予 VEGF 反义寡核苷酸 (VEGF-AS) 的 I 期研究
批准号:
7603936
负责人:
ALEXANDRA M LEVINE
金额:
$3.59万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

ALEXANDRA M LEVINE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. A Phase I study of VEGF-Antisense Oligonucleotide (VEGF-AS) given as a daily fixed dose subcutaneous injection in the treatment of patients with relapsed or refractory malignancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
  • 批准号:
    7716685
  • 项目类别:
  • 资助金额:
    $3.93万
  • 财政年份:
    2008
  • 负责人:
    ALEXANDRA M LEVINE
  • 依托单位:
A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY
  • 批准号:
    7716712
  • 项目类别:
  • 资助金额:
    $4.45万
  • 财政年份:
    2008
  • 负责人:
    ALEXANDRA M LEVINE
  • 依托单位:
University of Southern California
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
  • 批准号:
    7603909
  • 项目类别:
  • 资助金额:
    $24.41万
  • 财政年份:
    2006
  • 负责人:
    ALEXANDRA M LEVINE
  • 依托单位: